Journal rankings · indicator year 2013
Choose a field to open its ranking, or a journal to find its row in its subfield’s list.
Subfield ranking · 2013
Endocrinology, Diabetes and Metabolism journal rankings 2013
132 ranked journals · Subfield in Medicine
Endocrinology, Diabetes and Metabolism has 132 ranked journals in 2013. The median OJR fell 0.11 on 2012 to 0.87, below the world average of 1.00; Q1 starts at OJR 1.38. The top three are Endocrine Reviews, Diabetes Care, and Best Practice & Research Clinical Endocrinology & Metabolism.
Ranks and citation indicators: 2013. Journal access status and listed APC: source snapshot September 23, 2026.
Journals whose main subfield sits in this category and that published at least 30 citable documents (articles, reviews and conference papers) in 2010–2012, the window the 2013 score is computed on.
The OpenJournalRank Indicator (OJR) is a free, publicly available metric of a journal’s field-normalized citation impact, computed from open OpenAlex citation data. It compares citations to a journal’s papers from the previous three years with the world average for papers of the same subfield, year and type, so 1.00 is the world average and values can be compared across fields. It is computed with the NCI3 method.
The middle OJR among ranked journals in this category: half score higher, half lower. 1.00 is the world average for papers of the same subfield, year and type.
The dot is this category, the solid tick is the median of all ranked journals and the dashed line is the world average.
Share of ranked journals in this category that are fully open access, so every paper is free to read. Hybrid journals, which sell subscriptions and open single papers for a fee, are not counted.
Median list price of the article processing charge, in US dollars, among ranked journals in this category that list a price above zero. Journals with a listed APC of $0 and journals with no known price are left out of this median. The At a glance table below gives a second median that includes the $0 prices.
Subfields of Medicine (42)
- Surgery675
- Pulmonary and Respiratory Medicine266
- Public Health, Environmental and Occupational Health227
- Cardiology and Cardiovascular Medicine218
- Oncology170
- Infectious Diseases162
- Epidemiology157
- Endocrinology, Diabetes and Metabolism132
- Neurology132
- Radiology, Nuclear Medicine and Imaging129
- Physiology120
- Psychiatry and Mental health119
Show all 42 subfields
- Orthopedics and Sports Medicine88
- Dermatology73
- Pediatrics, Perinatology and Child Health73
- Ophthalmology70
- Hematology64
- Rheumatology56
- Obstetrics and Gynecology55
- Nephrology46
- Pharmacology40
- Reproductive Medicine40
- Complementary and alternative medicine39
- Geriatrics and Gerontology36
- Emergency Medicine34
- Otorhinolaryngology33
- Rehabilitation24
- Critical Care and Intensive Care Medicine22
- Pathology and Forensic Medicine22
- Hepatology18
- Genetics17
- Immunology and Allergy17
- Urology11
- Anesthesiology and Pain Medicine10
- Gastroenterology6
- Internal Medicine5
- Family Practice2
- Transplantation2
- Biochemistry1
- Health Informatics1
- Anatomy0
- Microbiology0
132 ranked journals
Filters
Rank is the position by OJR within the list on screen; 1 is the highest. | OJR is field-normalized 3-year citation impact: 1.00 is the world average for papers of the same subfield, year and type, so values compare across fields. The badge is the journal’s quartile in this list. | Citations per paper over a two-year window, counted from OpenAlex. It is not field-normalized, so compare it only between journals of the same field. ▲ or ▼ is the change from 2012. This is OpenJournalRank’s own count, not Clarivate’s Journal Impact Factor. | Citable documents (articles, reviews and conference papers) published in 2010–2012, the window the 2013 OJR is computed on. A journal needs at least 30 to be ranked. | Share of the journal’s 2010–2012 papers that are free to read in any open-access form. The green OA tag next to a title marks a fully open-access journal. | List price of the article processing charge in US dollars. “$0 listed” means the listed price is zero; a dash means no price is listed. | The line is the journal’s OJR from 2004 to 2013. | Compare |
|---|---|---|---|---|---|---|---|
1Endocrine ReviewsOxford University Press · United States | 7.95Q1 | 15.86 1.41 up from 2012 | 107 | 51% | $3,750 | ||
2Diabetes CareAmerican Diabetes Association · United States | 4.47Q1 | 9.06 0.42 down from 2012 | 1,852 | 96% | — | ||
3Best Practice & Research Clinical Endocrinology & MetabolismElsevier BV · United Kingdom | 3.47Q1 | 6.84 0.48 down from 2012 | 227 | 20% | $4,450 | ||
4The Journal of Clinical Endocrinology & MetabolismOxford University Press · United States | 3.43Q1 | 7.89 0.10 up from 2012 | 2,413 | 48% | $3,750 | ||
5Diabetes Obesity and MetabolismWiley · United Kingdom | 3.04Q1 | 7.38 0.96 up from 2012 | 507 | 27% | $5,380 | ||
6DiabetologiaSpringer Science+Business Media · Germany | 2.98Q1 | 7.82 1.48 up from 2012 | 1,112 | 69% | $3,490 | ||
7Reviews in Endocrine and Metabolic DisordersSpringer Science+Business Media · Netherlands | 2.82Q1 | 5.07 1.25 down from 2012 | 82 | 41% | $5,590 | ||
8Endocrine Related CancerBioscientifica · United Kingdom | 2.40Q1 | 5.84 0.42 up from 2012 | 294 | 91% | — | ||
9Endocrinology and Metabolism Clinics of North AmericaElsevier BV · United States | 2.37Q1 | 4.43 1.29 down from 2012 | 152 | 22% | $3,540 | ||
10Current Opinion in Endocrinology Diabetes and ObesityLippincott Williams & Wilkins · United Kingdom | 2.37Q1 | 5.09 0.44 down from 2012 | 222 | 18% | — | ||
11EndocrinologyOxford University Press · United States | 2.21Q1 | 5.38 0.14 up from 2012 | 1,669 | 55% | $3,750 | ||
12Journal of Internal MedicineWiley · United Kingdom | 2.18Q1 | 4.73 0.60 down from 2012 | 411 | 63% | $4,780 | ||
13Current Diabetes ReportsSpringer Science+Business Media · United States | 1.99Q1 | 4.43 0.83 up from 2012 | 269 | 33% | $4,890 | ||
14Journal of EndocrinologyBioscientifica · United Kingdom | 1.92Q1 | 4.41 0.11 down from 2012 | 414 | 93% | — | ||
15World Journal of DiabetesOAHong Kong SAR China | 1.92Q1 | 4.31 1.01 up from 2012 | 85 | 100% | — | ||
16European Journal of EndocrinologyOxford University Press · United Kingdom | 1.91Q1 | 4.68 0.32 up from 2012 | 742 | 27% | $4,292 | ||
17Current Diabetes ReviewsBentham Science Publishers · Netherlands | 1.87Q1 | 4.12 0.85 up from 2012 | 171 | 6% | — | ||
18Diabetes/Metabolism Research and ReviewsWiley · United Kingdom | 1.78Q1 | 4.30 0.77 up from 2012 | 359 | 15% | $4,780 | ||
19The Review of Diabetic StudiesOAGermany | 1.71Q1 | 2.87 0.35 down from 2012 | 81 | 100% | — | ||
20Diabetic MedicineWiley · United Kingdom | 1.71Q1 | 3.71 0.26 up from 2012 | 884 | 27% | $4,870 | ||
21Nutrition Metabolism and Cardiovascular DiseasesElsevier BV · Italy | 1.62Q1 | 3.64 0.18 up from 2012 | 450 | 26% | $3,000 | ||
22Diabetes and Vascular Disease ResearchOASAGE Publishing · United Kingdom | 1.57Q1 | 3.29 0.13 up from 2012 | 127 | 35% | $2,100 | ||
23Cardiovascular DiabetologyOABioMed Central · United Kingdom | 1.56Q1 | 4.89 0.24 down from 2012 | 367 | 100% | $4,290 | ||
24ThyroidMary Ann Liebert, Inc. · United States | 1.55Q1 | 3.36 0.47 down from 2012 | 805 | 39% | — | ||
25Diabetology & Metabolic SyndromeOABioMed Central · United Kingdom | 1.54Q1 | 3.58 0.58 up from 2012 | 163 | 100% | $2,890 | ||
26BMC Endocrine DisordersOABioMed Central · United Kingdom | 1.53Q1 | 2.80 1.37 down from 2012 | 72 | 100% | $3,190 | ||
27Diabetes & MetabolismElsevier BV · Netherlands | 1.49Q1 | 3.36 0.45 up from 2012 | 307 | 2% | $4,490 | ||
28MaturitasElsevier BV · Netherlands | 1.48Q1 | 3.67 0.10 up from 2012 | 597 | 25% | $4,390 | ||
29Clinical EndocrinologyWiley · United Kingdom | 1.47Q1 | 3.32 0.03 up from 2012 | 870 | 20% | $4,250 | ||
30Diabetes TherapyOAAdis, Springer Healthcare · United Kingdom | 1.47Q1 | 3.23 1.27 up from 2012 | 41 | 100% | $7,400 | ||
31Lipids in Health and DiseaseOABioMed Central · United Kingdom | 1.46Q1 | 3.31 0.24 up from 2012 | 572 | 100% | $2,990 | ||
32Diabetes Research and Clinical PracticeElsevier BV · Netherlands | 1.43Q1 | 3.62 0.88 up from 2012 | 973 | 23% | $4,410 | ||
33International Journal of EndocrinologyOAHindawi Publishing Corporation · United Kingdom | 1.38Q1 | 2.64 0.62 down from 2012 | 204 | 100% | $2,830 | ||
34Clinical TherapeuticsElsevier BV · United States | 1.34Q2 | 3.21 0.33 up from 2012 | 650 | 73% | $4,240 | ||
35Chronic IllnessSAGE Publishing · United Kingdom | 1.34Q2 | 2.12 0.59 down from 2012 | 90 | 43% | $4,150 | ||
36Journal of Diabetes and its ComplicationsElsevier BV · United States | 1.32Q2 | 2.55 0.24 down from 2012 | 205 | 33% | $3,760 | ||
37The Science of Diabetes Self-Management and CareSAGE Publishing · United States | 1.32Q2 | 2.52 0.14 down from 2012 | 181 | 26% | $4,400 | ||
38Diabetes Technology & TherapeuticsMary Ann Liebert, Inc. · United States | 1.30Q2 | 3.27 0.01 down from 2012 | 525 | 35% | — | ||
39Diabetes & Metabolism JournalOAKorean Diabetes Association · South Korea | 1.27Q2 | 2.79 0.49 up from 2012 | 164 | 100% | $500 | ||
40Menopause The Journal of The North American Menopause SocietyLippincott Williams & Wilkins · United States | 1.27Q2 | 3.06 0.40 up from 2012 | 701 | 24% | — | ||
41Endocrine PracticeElsevier BV · United States | 1.26Q2 | 2.94 0.05 up from 2012 | 552 | 7% | $3,480 | ||
42Postgraduate MedicineTaylor & Francis · United States | 1.21Q2 | 2.57 0.16 down from 2012 | 362 | 5% | — | ||
43Journal of Thyroid ResearchHindawi Publishing Corporation · United Kingdom | 1.20Q2 | 2.98 0.92 up from 2012 | 124 | 100% | $950 | ||
44Journal of DiabetesOAWiley · Australia | 1.16Q2 | 1.84 0.67 down from 2012 | 170 | 34% | $3,000 | ||
45Diabetes Metabolic Syndrome and ObesityOADove Medical Press · New Zealand | 1.16Q2 | 3.52 1.46 up from 2012 | 176 | 100% | $2,836 | ||
46Pediatric DiabetesWiley · Denmark | 1.15Q2 | 2.45 0.10 down from 2012 | 273 | 66% | $2,740 | ||
47ClimactericTaylor & Francis · United Kingdom | 1.14Q2 | 2.57 0.41 up from 2012 | 303 | 13% | — | ||
48PeptidesElsevier BV · United States | 1.12Q2 | 3.05 0.26 up from 2012 | 992 | 20% | $3,710 | ||
49Gender MedicineElsevier BV · United States | 1.09Q2 | 1.84 0.70 down from 2012 | 164 | — | — | ||
50Expert Review of Clinical PharmacologyTaylor & Francis · United Kingdom | 1.07Q2 | 2.55 1.03 up from 2012 | 199 | 25% | — |
Subfields of Medicine, with Endocrinology, Diabetes and Metabolism highlighted.
- Surgery675
- Pulmonary and Respiratory Medicine266
- Public Health, Environmental and Occupational Health227
- Cardiology and Cardiovascular Medicine218
- Oncology170
- Infectious Diseases162
- Epidemiology157
- Endocrinology, Diabetes and Metabolism132
- Neurology132
- Radiology, Nuclear Medicine and Imaging129
- Physiology120
- Psychiatry and Mental health119
- Orthopedics and Sports Medicine88
- Dermatology73
- Pediatrics, Perinatology and Child Health73
- Ophthalmology70
- Hematology64
- Rheumatology56
- Obstetrics and Gynecology55
- Nephrology46
- Pharmacology40
- Reproductive Medicine40
- Complementary and alternative medicine39
- Geriatrics and Gerontology36
- Emergency Medicine34
- Otorhinolaryngology33
- Rehabilitation24
- Critical Care and Intensive Care Medicine22
- Pathology and Forensic Medicine22
- Hepatology18
- Genetics17
- Immunology and Allergy17
- Urology11
- Anesthesiology and Pain Medicine10
- Gastroenterology6
- Internal Medicine5
- Family Practice2
- Transplantation2
- Biochemistry1
- Health Informatics1
- Anatomy0
- Microbiology0
Journals
Citations made in 2013. Corpus-wide, 76.9% of core-journal articles and reviews published that year have at least one matched reference; the share varies by journal and field.
40 additional Endocrinology, Diabetes and Metabolism journals with metrics are unranked under this release’s eligibility rules: a journal needs at least 30 citable documents in 2010–2012, at least 80% of them with a subfield, and a positive world-average expectation. Ranks are within the whole category; filters hide rows without re-ranking. OJR excludes self-citations.
At a glance
Indicator year: 2013. Publication window: 2010–2012. How these summaries are calculated
- Ranked journals
- 132
- Window papers (baseline)
- 56,103 +11.0% from indicator year 2010
- Median OJR
- 0.868 -14.1% from indicator year 2010
- Rising journals (2025)
- 11
Window papers are the baseline paper population: citable papers (articles, reviews and conference papers) from 2010–2012 in all journals of the world-average baseline, including non-core journals, counted by each paper’s own subfield. They are not the papers of the ranked journals alone.
| Measure | Year series | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ranked journals | 48 | 51 | 57 | 60 | 65 | 70 | 78 | 84 | 89 | 95 | 101 | 111 | 124 | 132 | 136 | 141 | 151 | 156 | 162 | 168 | 161 | 163 | 159 | 159 | 157 | 152 | |
| Window papers (baseline) | 21,857 | 24,171 | 25,806 | 27,521 | 27,880 | 30,069 | 32,732 | 36,738 | 40,740 | 46,752 | 50,540 | 53,888 | 54,290 | 56,103 | 58,424 | 61,715 | 64,393 | 66,581 | 68,391 | 70,385 | 72,729 | 75,894 | 79,750 | 82,000 | 83,560 | 87,039 | |
| Median OJR | 0.50 | 0.65 | 0.69 | 0.77 | 0.71 | 0.81 | 0.84 | 0.94 | 0.91 | 0.93 | 1.01 | 0.959 | 0.98 | 0.868 | 0.97 | 0.957 | 0.951 | 0.893 | 0.950 | 0.86 | 0.954 | 0.8896 | 0.8903 | 0.9170 | 0.9165 | 0.870 |
How to read these rankings
- OJR, the OpenJournalRank Indicator
- A field-normalized 3-year citation impact, computed from OpenAlex with the NCI3 method. It divides the citations a journal’s papers received by the world average for papers of the same subfield, year and type, so 1.00 is the world average and 2.00 means twice as many citations as expected. Because it is normalized, it can be compared across fields. Read the methodology
- Quartiles
- Q1 to Q4 split the ranked journals of the list you are viewing into four equal groups by OJR. A journal’s quartile depends on the list: the same journal can be Q1 in its subfield and Q2 among all journals.
- Impact factor (2-year)
- Citations per paper over a two-year window, counted from OpenAlex. It is easy to compare with familiar impact factors but is not field-normalized, so compare it only within a field. It is not Clarivate’s Journal Impact Factor. Why it differs from the Journal Impact Factor
- Rank ranges
- Each rank in the latest year carries a likely range from 1,000 resamples of the journal’s papers. Where two journals’ ranges overlap, the data cannot tell them apart, so treat neighbouring ranks as ties.